| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 65.4% | -8.76% | -1.18% | 35/132 | 51.53% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 66.18% | -5.75% | -6.07% | 31/132 | 51.65% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 70.46% | -1.6% | -0.3% | 22/132 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 70.67% | 11.15% | -1.4% | 24/132 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 71.68% | 6.96% | 2.08% | 23/132 | 53.25% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 70.22% | 6.06% | -1.93% | 28/132 | 53.3% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 71.6% | 6.63% | 12.61% | 28/132 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 63.59% | -20.12% | -5.12% | 48/132 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 67.01% | -17.29% | 1.22% | 37/132 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 66.21% | -18.39% | -1.41% | 38/132 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 67.15% | -17.71% | -15.64% | 36/132 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 79.6% | 25.41% | -1.76% | 10/132 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 81.03% | 116.94% | -0.13% | 10/132 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 81.13% | 120.66% | -0.58% | 9/132 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 81.6% | 113.34% | 28.55% | 9/132 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 63.47% | 12.73% | 69.95% | 55/132 | 57.29% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 37.35% | -35.78% | 1.59% | 91/132 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 36.77% | -39.25% | -3.87% | 98/132 | 58.42% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 38.25% | -15.31% | -32.07% | 81/132 | 60.75% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 56.31% | 95.58% | -3.18% | 78/132 | 59.59% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 58.16% | 106.19% | -3.91% | 54/132 | 61.59% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 60.52% | 101.09% | 34.01% | 57/132 | 59.94% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 45.16% | 43.66% | 56.87% | 53/132 | 58.33% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 28.79% | -3.9% | 2.07% | 104/132 | 56.37% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 28.21% | -1.32% | -6.28% | 57/132 | 55.22% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 30.1% | 5.07% | -4.26% | 65/132 | 57.37% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 31.44% | -16% | 4.93% | 45/132 | 52.04% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 29.96% | -2.12% | 4.81% | 98/132 | 55.53% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 28.58% | -9.06% | -0.21% | 48/132 | 51.47% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 28.64% | -10.87% | -23.46% | 51/132 | 51.56% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 37.43% | -11.94% | 22.26% | 35/132 | 50.98% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 30.61% | -5.29% | -2.61% | 91/132 | 55.34% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 31.43% | 4.25% | -2.2% | 40/132 | 52.35% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 32.14% | -9.5% | -24.38% | 47/132 | 53.87% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 42.5% | 13.77% | 31.51% | 29/132 | 52.96% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 32.32% | 25.7% | 7.2% | 68/132 | 56.43% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 30.15% | 3.63% | -15.11% | 35/132 | 50.39% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 35.51% | 21.27% | -4.94% | 38/132 | 51.46% | 明德生物 | 86.71% | 行业排名> |
| 2016-03-31 | 37.36% | 12.76% | 45.3% | 26/132 | 48.15% | 健帆生物 | 83.86% | 行业排名> |
| 2015-12-31 | 25.71% | -17.65% | -11.62% | 58/132 | 53.26% | 正海生物 | 94.02% | 行业排名> |
| 2015-09-30 | 29.09% | -10.52% | -0.66% | 29/132 | 47.96% | 冠昊生物 | 84.57% | 行业排名> |
| 2015-06-30 | 29.28% | -11.73% | -11.61% | 40/132 | 51.86% | 艾德生物 | 94.5% | 行业排名> |
| 2015-03-31 | 33.13% | -18.67% | 6.11% | 28/132 | 48.84% | 基蛋生物 | 85.13% | 行业排名> |

微信公众号
证券之星APP



